.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Teva
Fuji
Cipla
Johnson and Johnson
Healthtrust
Covington
UBS
Farmers Insurance
Medtronic

Generated: September 20, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018920

« Back to Dashboard
NDA 018920 describes M.V.I. PEDIATRIC, which is a drug marketed by Hospira and is included in one NDA. It is available from one supplier. Additional details are available on the M.V.I. PEDIATRIC profile page.

The generic ingredient in M.V.I. PEDIATRIC is ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; phytonadione; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; phytonadione; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e profile page.

Summary for NDA: 018920

You have an error in your SQL syntax; check the manual that corresponds to your MariaDB server version for the right syntax to use near 'SODIUM','THIAMINE HYDROCHLORIDE','VITAMIN A','VITAMIN E') AND hsdb_drugname IS N' at line 1
Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0